v3.25.0.1
Income Taxes
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Income Taxes
14.
INCOME TAXES

Deferred income taxes consist of the following as of December 31, 2024 and 2023 (in thousands):

 

 

As of December 31,

 

 

2024

 

 

2023

 

Deferred Income Tax Assets

 

 

 

 

 

Net Operating Loss Carryforwards

$

308,669

 

 

$

195,378

 

IRC §163(j) Interest Expense Limitation Carryover

 

29,239

 

 

 

18,785

 

Lease Liability

 

7,997

 

 

 

9,496

 

Research and Development

 

118,649

 

 

 

68,411

 

Excess of Tax Basis over Book Basis Fixed Assets

 

4,696

 

 

 

2,473

 

Deferred Revenue

 

19,708

 

 

 

10,457

 

Revenue Reserve Liability

 

2,812

 

 

 

3,748

 

Stock Compensation

 

26,441

 

 

 

40

 

Other

 

1,077

 

 

 

4,739

 

 

$

519,288

 

 

$

313,527

 

Less Valuation Allowance

 

(503,071

)

 

 

(297,294

)

 

$

16,217

 

 

$

16,233

 

Deferred Income Tax Liabilities

 

 

 

 

 

Unrealized Gain/Loss on Marketable Equity Securities

 

(3,878

)

 

 

(2,420

)

Right of Use Asset

 

(3,615

)

 

 

(5,067

)

Warrant Contract Asset

 

(7,697

)

 

 

(7,513

)

Other

 

(1,261

)

 

 

(1,356

)

 

$

(16,451

)

 

$

(16,356

)

Net Deferred Income Tax Asset (Liability)

$

(234

)

 

$

(123

)

 

The provision for income taxes consists of the following for the years ended December 31, 2024, 2023 and 2022 (in thousands):

 

 

Year Ended December 31,

 

 

2024

 

 

2023

 

 

2022

 

Current tax expense (benefit)

 

 

 

 

 

 

 

 

Federal

$

0

 

 

$

—

 

 

$

—

 

State

 

(33

)

 

 

13

 

 

 

66

 

Foreign

 

188

 

 

 

152

 

 

 

—

 

Total

$

155

 

 

$

165

 

 

$

66

 

Deferred tax expense (benefit)

 

 

 

 

 

 

 

 

Federal

 

(175,070

)

 

 

(45,738

)

 

 

(59,141

)

State

 

(30,450

)

 

 

(7,017

)

 

 

(7,686

)

Foreign

 

(146

)

 

 

—

 

 

 

—

 

Total

 

(205,666

)

 

 

(52,755

)

 

 

(66,827

)

Change in valuation allowance

 

205,777

 

 

 

52,878

 

 

 

66,827

 

Total income tax expense (benefit)

$

266

 

 

$

288

 

 

$

66

 

 

The components of income before income taxes as follows (in thousands):

 

 

Year Ended December 31,

 

 

2024

 

 

2023

 

 

2022

 

Domestic

$

(701,648

)

 

$

(213,522

)

 

$

(289,556

)

Foreign

 

339

 

 

 

(243

)

 

 

398

 

 

A reconciliation of the difference between the federal statutory rate and the effective income tax rate as a percentage of income before taxes for the years ended December 31, 2024, 2023 and 2022:

 

 

Year Ended December 31,

 

 

2024

 

 

2023

 

 

2022

 

Federal Statutory Tax Rate

 

21.00

%

 

 

21.00

%

 

 

21.00

%

State Statutory Tax Rate

 

4.35

%

 

 

3.28

%

 

 

2.64

%

Foreign

 

0.00

%

 

 

(0.09

%)

 

 

0.03

%

Stock Compensation

 

5.60

%

 

 

0.00

%

 

 

0.00

%

Officer Compensation

 

(1.46

%)

 

 

0.00

%

 

 

0.00

%

Other Permanent Differences

 

(0.17

%)

 

 

0.47

%

 

 

(0.29

%)

Other

 

(0.02

%)

 

 

(0.06

%)

 

 

(0.29

%)

Change in Valuation Allowance

 

(29.34

%)

 

 

(24.74

%)

 

 

(23.11

%)

Total

 

(0.04

%)

 

 

(0.14

%)

 

 

(0.02

%)

 

Net change in valuation allowance as follows (in thousands):

 

 

Year Ended December 31,

 

 

2024

 

 

2023

 

 

2022

 

Valuation Allowance, beginning of year

$

297,294

 

 

$

244,064

 

 

$

161,749

 

Charges

 

205,777

 

 

 

52,878

 

 

 

66,827

 

Purchase accounting adjustments

 

—

 

 

 

352

 

 

 

15,488

 

Valuation Allowance, end of year

$

503,071

 

 

$

297,294

 

 

$

244,064

 

 

For the year ended December 31, 2024, the Company recognized stock-based compensation windfall of $46.0 million (tax-effected).

 

The Company’s income tax expense as recorded in the financial statements differs from the benefit computed by applying statutory tax rates to net loss before income taxes due to permanent differences related to the deductibility of certain expenses and the valuation allowance. Current income tax expense for the years ended December 31, 2024, 2023 and 2022, related to state and foreign expense was not material.

As of December 31, 2024 the Company had federal net operating loss (“NOL”) carry forwards of $257.0 million (tax effected) and state NOL carry forwards of approximately $51.7 million (tax effected), which may be available to offset future taxable income. The federal NOLs will begin to expire in 2037 and the state NOLs will begin to expire in 2028. A full valuation allowance has been recorded against the NOL carry forwards.

The Company files income tax returns in the U.S. federal jurisdiction and various state jurisdictions. Due to its operating loss carryforwards, the U.S. federal statute of limitations remains open for tax year 2016 and onward and the Company continues to be subject to examination by the Internal Revenue Service for tax years 2016 and later. The resolutions of any examinations are not expected to be material to these financial statements. As of December 31, 2024 and 2023, there are no penalties or accrued interest recorded in the consolidated financial statements. The calculation of the Company’s tax obligations involves dealing with uncertainties in the application of complex tax laws and regulations. ASC 740, Income Taxes, provides that a tax benefit from an uncertain tax position may be recognized when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, on the basis of the technical merits. The Company has assessed its income tax positions and recorded tax benefits for all years subject to examination, based upon its evaluation of the facts, circumstances and information available at each period end. For those tax positions where the Company has determined there is a greater than 50% likelihood that a tax benefit will be sustained, the Company has recorded the largest amount of tax benefit that may potentially be realized upon ultimate settlement with a taxing authority that has full knowledge of all relevant information. For those income tax positions where it is determined there is less than 50% likelihood that a tax benefit will be sustained, no tax benefit has been recognized. The Company had no uncertain tax positions during the years ended December 31, 2024, 2023 and 2022.

The Company recognizes interest and, if applicable, penalties for any uncertain tax positions. Interest and penalties are recorded as a component of income tax expense. In the years ended December 31, 2024, 2023 and 2022, the Company did not have any accrued interest or penalties associated with any unrecognized tax benefits.

The Company does not provide for U.S. income taxes on unremitted earnings of foreign subsidiaries. Unremitted earnings of foreign subsidiaries were immaterial on December 31, 2024 and 2023.